Omneity® Pellets
All-In-One Vitamin & Mineral Pellet
Topic:Glucose
Glucose is a simple sugar that serves as a primary energy source for horses. It is metabolized through various biochemical pathways to support cellular functions and overall energy requirements. In equine physiology, glucose levels are influenced by factors such as diet, exercise, and metabolic health. Monitoring glucose concentrations is important for understanding metabolic conditions, such as insulin resistance and equine metabolic syndrome, which can affect a horse's health and performance. This page compiles peer-reviewed research studies and scholarly articles that explore the regulation, metabolism, and clinical implications of glucose in equine health.
Effect of canagliflozin on insulin sensitivity in insulin-dysregulated horses as assessed by euglycemic hyperinsulinemic clamp: a randomized, placebo-controlled trial. Insulin resistance, enhanced β-cell responsiveness, and lower insulin clearance contribute to hyperinsulinemia in horses with insulin dysregulation. Canagliflozin (CAN) reduces hyperinsulinemia in horses, but its effect on insulin sensitivity (IS) remains unclear. Objective: Evaluate the effects of CAN on IS and insulin clearance using a euglycemic hyperinsulinemic clamp (EHC) and on β-cell responsiveness using a graded glucose infusion test (GGI) in insulin-dysregulated (ID) horses. Methods: Twenty privately owned ID mares. Methods: In this randomized, double-blind, placebo-controlled study...
Effects of acute dopamine infusion on metabolic and endocrine responses in horses with different endocrine phenotypes: an exploratory fixed-sequence study. Dopamine modulates insulin secretion and sensitivity in other species, but its peripheral metabolic effects in horses remain unclear. We evaluated whether continuous dopamine hydrochloride (DA HCl) infusion alters oral carbohydrate-stimulated insulin responses or peripheral insulin sensitivity in horses with different metabolic classifications. Seven horses completed oral sugar tests (OST) and hyperinsulinemic-euglycemic clamps (EHC) under control conditions and during DA HCl infusion (2.5 µg/kg/min), with each horse serving as its own control. Horses were classified separately as normoinsu...
An in-feed oral glucose test increases post-prandial high molecular weight adiponectin concentration in horses. Adiponectin is a fat-derived adipocytokine that has been associated with laminitis risk in ponies. Factors that affect sampling timing for measurement of adiponectin concentration have been inadequately investigated. This study aimed to determine the effect of an oral glucose test (OGT) and fed-state on adiponectin concentration in horses and ponies. Blood samples were collected before and after an OGT in 85 horses and ponies and high molecular weight (HMW) adiponectin concentration was measured. Total adiponectin concentration was measured in a subset of 25 animals. Assays validated for use w...
Effect of canagliflozin treatment on β-cell responsiveness in insulin-dysregulated horses: a 4-week, multi-arm, double-blind, randomized clinical trial. The sodium-glucose co-transporter 2 (SGLT2) inhibitor canagliflozin (CAN) decreases hyperinsulinemia in insulin-dysregulated (ID) horses, but its effects on pancreatic β-cell responsiveness to glucose are unknown. Objective: Compare the effects of 2 CAN dosages (0.6 and 1.2 mg/kg) with placebo (PBO) on β-cell responsiveness to IV glucose in ID horses using a graded glucose infusion (GGI) test. Methods: Forty-two privately-owned ID horses. Methods: Randomized, multicenter, double-blind, parallel-group, multi-arm, PBO-controlled study. Horses underwent GGI testing before and after 4 weeks of...
Melatonin as a daily rhythm control signal for glucose homeostasis and insulin secretion in horses. An involvement of melatonin in the regulation of glucose homeostasis and insulin secretion in pancreatic β-cells has been proposed. To evaluate the features of the daily rhythms of plasma melatonin, blood glucose, and insulin in horses, ten clinically healthy Italian Saddle geldings, 9-10 years old with a mean body weight of 490 ± 25 kg, were enrolled. The animals were housed in individual boxes under natural environmental conditions (sunrise 06:10; sunset 18:10; 12-15°C, 77% RH). All horses were cannulated the day before the start of the study for sample collection, which was perfo...
The effects of feeding frequency on glycemia and insulinemia in moderately exercised young horses. Concentrates are typically fed twice daily to supplement forages in horses to facilitate management, especially those with higher energy needs, but high-grain meals can contribute to digestive and metabolic challenges, including insulin dysregulation. This study investigated the effects of feeding frequency on glycemia, insulinemia, and insulin sensitivity measured by an oral sugar test in moderately exercised young horses. Thirty-two healthy Quarter Horses (2-3 years old) were assigned to either traditional feeding (TF; two grain meals/day) or fractioned feeding (FF; automated grain delivery...
The effect of ertugliflozin on serum insulin and glucose in healthy horses receiving dexamethasone. Sodium-glucose cotransporter 2 inhibitors (SGLT-2i) can be used to manage insulin dysregulation (ID). Their effect on corticosteroid-induced ID is unknown. Objective: Evaluate effects of ertugliflozin on serum insulin and glucose concentrations in horses receiving dexamethasone (DEX). We hypothesized that DEX would induce ID and ertugliflozin coadministration would mitigate that effect. Methods: Seven healthy horses. Methods: Randomized crossover design; horses received DEX (0.06 mg/kg IV q48h; DEX)or ertugliflozin (0.05 mg/kg PO q24h) plus DEX (SGLT-2i group) for seven days. Oral sugar (OST...
Pancreatic α-cell dysfunction associated with equine insulin dysregulation. Insulin dysregulation (ID) in horses is characterised by insulin resistance and exaggerated insulin responses, yet the underlying endocrine mechanisms remain incompletely understood. In humans, α-cell dysfunction characterised by exaggerated glucagon secretion contributes to metabolic disease; however, the role of pancreatic α-cell function in equine ID has not previously been investigated. Objective: To investigate whether horses with moderate to severe ID exhibit α-cell dysfunction, characterised by fasting and postprandial hyperglucagonaemia as well as impaired postprandial glucagon supp...
Hypothalamic-pituitary-adrenal axis response and glucose homeostasis during exercise to fatigue before and after training in old and young adult Standardbred mares. While reduced cortisol responses to exercise have been described in older horses, the effects of aging and training on the hypothalamic-pituitary-adrenal axis (HPA axis) and downstream metabolic signaling are currently unknown. Unassigned: This study tested the hypothesis that age and exercise training alter the response of the HPA axis, insulin, and glucose during an acute exercise challenge to fatigue. Methods: Six old (22.0±0.7 years) and six young adult (7.3±0.6 years) unfit Standardbred mares were tested. Mares ran a graded exercise test before (GXT1) and after (GXT2) 8 weeks of trainin...
Efficacy and safety of canagliflozin in insulin dysregulated horses: a 4-week multi-arm, double-blind, randomized, clinical trial. Sodium-glucose cotransporter-2 (SGLT2) inhibitors are promising drugs for treatment of hyperinsulinemia in insulin-dysregulated (ID) horses. Objective: Compare short-term effects of the SGLT2 inhibitor canagliflozin versus placebo on glucose and insulin responses during an oral sugar test (OST) and a forage-based feed challenge test (FCT), and to assess adverse effects. Methods: Forty-two privately owned severely ID horses. Methods: Multi-center, randomized, double-blind, placebo-controlled, parallel-group study. Horses were allocated (1:1:1) to receive canagliflozin (0.6 or 1.2 mg/kg PO q24h...
Meta-Analysis and Physiologically-Based Modeling of the Pharmacokinetics and Pharmacodynamics of Dexamethasone in Horses. Dexamethasone (DEX) is widely used in equine practice for its potent anti-inflammatory effects and diverse studies have examined its pharmacology in horses. We integrated all available pharmacokinetic (PK) and pharmacodynamic (PD) data from 12 studies to quantify DEX disposition and endocrine effects in horses. Methods: DEX concentrations in blood, urine and synovial fluid, plus cortisol (CTS) and glucose (GLU) in plasma, following various administration routes (intravenous (IV), intramuscular (IM), intra-articular, oral) were available from original studies or digitized from literature. A mi...
Comparative hematological and serum biochemical profiling of grassland Xichun and Xilingol horses. The Grassland Xichun horse is an emerging crossbred population developed from Xilingol mares and Thoroughbred stallions in Inner Mongolia, China, yet its blood physiological profile has not been systematically characterized. In this study, we compared 32 hematological and serum biochemical parameters between 177 Grassland Xichun horses and 35 Xilingol horses maintained under the same extensive grazing conditions. Following Benjamini-Hochberg FDR correction, 17 of 32 parameters differed significantly between breeds. Grassland Xichun horses showed markedly higher RBC count (9.145 vs 7.905 × 10...
Metabolic effects and pharmacokinetics of oral cannabidiol (CBD) in Connemara ponies following 21 days of treatment. Cannabidiol (CBD) has gained interest in equine medicine due to its potential therapeutic effects. Preclinical studies suggest that CBD may influence metabolic pathways relevant to metabolic syndrome, which present in both human and equine populations. The aim of this study was to evaluate the effects of oral CBD on metabolic parameters in Connemara ponies and to characterize its pharmacokinetics. Unassigned: A total of 13 Connemara ponies [seven with equine metabolic syndrome (EMS)] were stratified by EMS status and age and randomly assigned to a CBD-treated group (2 mg/kg orally, twice dai...
Bexagliflozin controls hyperinsulinemia in horses with naturally occurring insulin dysregulation: a placebo-controlled crossover trial. To evaluate bexagliflozin for insulin control in horses with naturally occurring insulin dysregulation. Unassigned: In a randomized, placebo-controlled crossover study, 10 client-owned Arabian horses with hyperinsulinemia (> 30 μIU/mL) were treated with bexagliflozin (0.03 mg/kg, PO, q 24 h; BEXA03) or placebo control for a 10-day treatment period, crossing over after a 4-day washout. After a further 12-day washout, 8 of the horses were treated with bexagliflozin (0.06 mg/kg, PO, q 24 h; BEXA06) for an additional 7-day treatment period. Oral sugar tests were performed at the beginning of e...
Ertugliflozin decreases the insulin spike in non-insulin dysregulated standardbred horses following intra-articular triamcinolone administration. Horses with equine metabolic syndrome (EMS) are at an increased risk of laminitis following corticosteroid use. Ertugliflozin reduces hyperinsulinemia in horses with EMS, and therefore may be a management option to reduce the insulin spike seen post corticosteroid use. It was hypothesised that oral ertugliflozin, administered before and after intra-articular (IA) triamcinolone acetonide (TA), will significantly lower the insulin response in comparison to placebo. A randomised, blinded, placebo-controlled, crossover design was performed on eight adult standardbred geldings with no history of la...
Evaluation of the tolerance and effects of 1-deoxynojirimycin on insulin and glucose dynamics in healthy horses and horses at risk for insulin dysregulation. Insulin dysregulation (ID) is common and diminishes welfare of horses. Current management relies on diet and exercise, with variable responses and limited medical options. Alpha-glucosidase inhibitors (AGIs) might provide adjunctive therapy. Objective: To evaluate the tolerance and effects of Reducose®, a Morus alba leaf extract standardized to 5% 1-deoxynojirimycin (DNJ), in healthy horses and horses at risk of ID. We hypothesized DNJ would be well-tolerated and reduce insulin responses to oral sugar tests (OSTs). Methods: Twenty-seven horses: 6 healthy (Phase I), 5 at risk for ID (Phase II)...
Effects of vatinoxan in horses sedated with detomidine and butorphanol for gastroscopy: a randomized clinical study. The peripheral alpha2-adrenoceptor antagonist vatinoxan attenuated the side effects of alpha2-adrenergic sedatives in experimental studies in horses. This clinical study investigated the effects of vatinoxan in horses sedated for gastroscopy with detomidine and butorphanol. Client-owned horses were randomly allocated to receive one of the following two intravenous treatments: detomidine hydrochloride (HCl) (12μg/kg) + butorphanol tartrate (12μg/kg) (DB; n=11) or DB + vatinoxan HCl (200μg/kg) (DBV; n=11). Borborygmi score and heart rate were recorded by auscultation. Sedation level was evalu...
Equine Oocyte and Embryo Metabolism in the ART Setting: Current Knowledge and Clinical Significance. Equine in vitro embryo production has become very efficient and is used extensively worldwide for the clinical production of foals. What we know so far about offspring health and performance is promising; however, elements of the in vitro process remain unphysiological when compared to in vivo conditions. Studying the metabolism of oocytes and embryos can help inform the optimisation of culture systems and identify aberrations if they occur. Given the growing body of knowledge on the downstream effects of an inadequate peri-conception environment, both in vivo and in vitro, it is imperative th...
Saliva and plasma metabolome analysis during the five days before foaling in the mare. Saliva is a relevant biofluid for real-time welfare-friendly monitoring of systemic events in animals, because some bioanalytes have a systemic origin and its collection is painless, stress-free and non-invasive. Our aim was to analyze the metabolome of equine saliva during the five days before foaling, with a focus on identifying metabolites whose level significantly changed before parturition, that could be potential salivary biomarkers of the onset of parturition. We compared the saliva and plasma metabolomes to investigate their relationship. Saliva and blood samples were collected from tw...
Targeted metabolomics reveals the impact of glucose and pyruvate on energy metabolism and storage potential of stallion spermatozoa. Oxidative phosphorylation is the main source of ATP for the stallion spermatozoa. Consequently, metabolites that favor mitochondrial function are receiving increased interest. However, glycolysis itself may be the major source of pyruvate and acetyl-CoA. Objective: To determine the contribution of glycolysis to feed the tricarboxylic acid cycle to generate the reducing equivalents for the electron transport chain. Methods: We stored stallion spermatozoa in the presence of different concentrations of glucose and pyruvate (1mM glucose /1mM pyruvate, 1mM glucose /10 mM pyruvate, 40 mM glucose / 1...
Temporal variation in incretin and insulin secretion in ponies in association with dietary macronutrients. Equine insulin dysregulation (ID) is a common condition that predisposes to hyperinsulinaemia-associated laminitis. Improved pathophysiological understanding would enable better management of ID and reduce the risk of laminitis. The incretin peptides, glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), augment the insulin response to dietary glucose and GLP-1 has been implicated in the pathophysiology of ID. However, their temporal variation in response to a low-energy diet has not been reported. This study determined the variation in GLP-1, GIP and insulin ...
Blood and fecal metabolic responses of mature horses fed rhizoma peanut hay. Rhizoma peanut (RP, Arachis glabrata Benth) is an alternative legume forage to alfalfa (ALF, Medicago sativa L.) with less non-structural carbohydrates and crude protein. Yet, metabolic responses to consuming RP hay have never been evaluated in horses. Objective: The objective of this study was to investigate the effect of feeding RP 'Florigraze' hay on fecal and blood metabolic variables compared to alfalfa 'Legendary XHD' and bermudagrass (BMG, Cynodon dactylon L. 'Coastal') hays fed to maintenance horses. Methods: Six mature Quarter Horse geldings (596±40 kg) were randomly assigned to one ...
The Effect of Seasonal Changes in Non-Structural Carbohydrates in Pasture on the Metabolic Profile of Horses with Laminitis. This study aimed to examine the seasonal dynamics of non-structural carbohydrates in pasture and their relationship to metabolic indicators in horses with a history of laminitis. Thirty Hucul mares were divided into a laminitis group (LG, = 15) and a control group (CG, = 15). Insulin, glucose, fructosamines concentrations and body weight were monitored during four sampling periods (S0-S3), while pasture variables were analyzed during three periods (S1-S3). The concentration of water-soluble carbohydrates was highest in May (126.8 g/kg DM) and measured lower in October (57.9 g/kg DM), while s...
Effects of total parenteral nutrition and electrolyte solutions with or without glutamine on the hormonal profiles of horses subjected to exploratory laparotomy. Starvation and nutritional support clinically influence horses, particularly during the treatment of gastrointestinal diseases and post-surgical recovery. In this study, we aimed to evaluate the effects of different nutritional strategies on the endocrine response of horses subjected to exploratory laparotomy followed by food deprivation. Sixteen healthy adult horses were randomly allocated into four groups (n=4) based on treatments: enteral fluid therapy without (ENTFL) or with glutamine (ENTGL), and parenteral fluid therapy with glucose (PARFL) or total parenteral nutrition with glutamine (P...
Single-cell metabolic profiling of stallion spermatozoa by flow cytometry using NADH and FAD autofluorescence†. The metabolic activity of stallion spermatozoa was assessed using flow cytometry to detect NAD(P)H and FAD fluorescence without labels. Sperm were incubated with different energy sources-glucose, lactate, and pyruvate-individually or combined, and measurements of NAD(P)H, FAD, NAD(P)H/FAD ratio, and optical redox ratio (ORR) were taken. Additionally, a metabolic assay based on resazurin reduction and flow cytometry detection was developed. Changes in NAD(P)H and FAD fluorescence, the NAD(P)H/FAD ratio, and ORR were observed. The NAD(P)H/FAD ratio increased significantly, especially when glucos...
High glucose in the extender impacts the metabolic phosphoproteome and modifies the phosphorylation of AKAP4 in stallion spermatozoa. Commercial extenders for equine semen typically contain high glucose concentrations; however, recent research indicates that these supraphysiological concentrations of glucose may be detrimental. Spermatozoa lack translational activity and depend on post-translational protein modifications for their regulation. Supraphysiological glucose concentrations are known to modify cell regulation, and we hypothesize that post-translational modification deregulation associated with supraphysiological glucose concentrations occurs in spermatozoa extended in high glucose media; and increasing the concentr...
Effect of transdermal melatonin on circulating cortisol and blood chemistry in horses exposed to transport stress. Our objective was to evaluate the effect of transdermal melatonin on physiological stress biomarkers in horses, with some subjected to transport stress. Sixteen horses were assigned to a 2 × 2 factorial design assessing treatment (melatonin vs. no melatonin) and transport status (transported vs. non-transported), creating four groups: Control (CON), Transport only (TRS), Melatonin only (MEL), and Melatonin plus Transport (MELTRS). Horses in melatonin groups received 24 mg/day transdermally for 21 days and transported groups underwent a 3-hour trailer ride on day 21. Day 21 blood samples were ...
Sodium-glucose transporters SGLT1 and SGLT2 in equine renal, hepatic and pancreatic tissue. Insulin dysregulation is a hallmark of equine metabolic syndrome (EMS), and in recent years, pharmacological treatment with sodium-dependent glucose transporter 2 inhibitors (SGLT2i) have shown promise in reducing the risk of hyperinsulinemia-associated laminitis in horses diagnosed with EMS. In humans and laboratory animals, this transporter protein is responsible for the majority of renal tubular glucose reabsorption, however, the presence of this and the related sodium-dependent glucose transporter 1 (SGLT1) have not yet been studied in equine kidneys. Additionally, studies in humans and la...
